LEF1 and colorectal carcinoma: In CRC, NIC blocks DCLK1-B transcription by disrupting the binding of LEF1 to the DCLK1-B promoter, and reduces the expression of DCLK1-B, leading to increased apoptosis, thus making CRC more sensitive to radiotherapy and chemotherapy [42].